Literature DB >> 18486170

Neurotoxic envenoming by South American coral snake (Micrurus lemniscatus helleri): case report from eastern Ecuador and review.

Stephen R Manock1, German Suarez, David Graham, María L Avila-Aguero, David A Warrell.   

Abstract

A man bitten by a large coral snake (Micrurus lemniscatus helleri) in the Amazon basin of Ecuador developed persistent excruciating pain in the bitten arm. On admission to hospital less than 30 min later, he had a polymorphonuclear leucocytosis, thrombocytopenia and mildly prolonged prothrombin time/partial thromboplastin time. Not until 14 h after the bite did he develop the first signs of neurotoxicity. Despite treatment with specific antivenom 50 h after the bite, he required oxygen for respiratory failure 60 h, and 6 h of mechanical ventilation 72 h, after the bite. Over the next 38 h, he required two further intubations and periods of assisted ventilation before being airlifted to a tertiary referral hospital. Complications included bacterial pneumonia, pneumothorax, bronchial obstruction by mucus plugs and mild rhabdomyolysis. He was discharged from hospital 15 days after the bite with persistent limb weakness and urinary incontinence but eventually recovered. The interesting and unusual features of this case (severe local pain, very slow evolution of neurotoxic envenoming, persistent thrombocytopenia and mild coagulopathy) are discussed in the context of what is known of the composition of Micrurus venoms and the small clinical literature on envenoming from their bites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486170     DOI: 10.1016/j.trstmh.2008.03.026

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Ancient Diversification of Three-Finger Toxins in Micrurus Coral Snakes.

Authors:  Daniel Dashevsky; Bryan G Fry
Journal:  J Mol Evol       Date:  2018-01-27       Impact factor: 2.395

2.  Venomous snakebites in the Croatian North Dalmatia region.

Authors:  Robert Karlo; Boris Dželalija; Božidar Zupančić; Ivan Bačić; Tihomir Dunatov; Ante Kanjer; Rade Skarica; Srećko Sabalić; Nado Bukvic; Harry Nikolić; Goran Augustin
Journal:  Wien Klin Wochenschr       Date:  2011-11-29       Impact factor: 1.704

3.  Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization.

Authors:  Gabriela D Tanaka; Maria de Fátima D Furtado; Fernanda C V Portaro; Osvaldo Augusto Sant'Anna; Denise V Tambourgi
Journal:  PLoS Negl Trop Dis       Date:  2010-03-09

4.  The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom.

Authors:  Daryl C Yang; James Dobson; Chip Cochran; Daniel Dashevsky; Kevin Arbuckle; Melisa Benard; Leslie Boyer; Alejandro Alagón; Iwan Hendrikx; Wayne C Hodgson; Bryan G Fry
Journal:  Neurotox Res       Date:  2017-07-03       Impact factor: 3.911

5.  The neuromuscular activity of Micrurus pyrrhocryptus venom and its neutralization by commercial and specific coral snake antivenoms.

Authors:  Thiago Magalhães Camargo; Adolfo Rafael de Roodt; Maria Alice da Cruz-Höfling; Léa Rodrigues-Simioni
Journal:  J Venom Res       Date:  2011-06-24

Review 6.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

Review 7.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

8.  Evaluation of systemic inflammatory response and lung injury induced by Crotalus durissus cascavella venom.

Authors:  Elen Azevedo; Ricardo Gassmann Figueiredo; Roberto Vieira Pinto; Tarsila de Carvalho Freitas Ramos; Geraldo Pedral Sampaio; Rebeca Pereira Bulhosa Santos; Marcos Lázaro da Silva Guerreiro; Ilka Biondi; Soraya Castro Trindade
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.